CEO: | Carolyn Cross |
Chairman: | Jean Charest |
Chief Technology Officer: | Nicolas Loebel |
Independent Non-Executive Director: | Simon Sinclair |
Independent Non-Executive Director: | Junaid Bajwa |
Interim CFO: | Kwong Choo |
Senior Independent Non-Executive Director: | Jean Duvall |
Non-Executive Dir: | Craig Tooman, Michael Farrar |
Address: | 888 - 1100 Melville Street, Vancouver, British Columbia, Canada, V6E 4A6 |
Phone: | +1 604 669 0555 |
Website: | https://ondinebio.com/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | CA68234M2058 |
Currency | UK Pounds |
Share Price | 5.38p |
Change Today | -0.13p |
% Change | -2.27 % |
52 Week High | 19.00 |
52 Week Low | 5.25 |
Volume | 53,973 |
Shares Issued | 226.75m |
Market Cap | £12.19m |
Beta | 0.06 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
15:35 | 25,000 @ 5.25p |
15:33 | 25,000 @ 5.25p |
12:22 | 2,973 @ 5.25p |
12:22 | 1,000 @ 5.50p |
Chair | Jean Charest |
CEO | Carolyn Cross |
You are here: research